Written and maintained by CASRAI Editorial Board
Last updated
The Five Times Sit-to-Stand Test (5xSTS or FTSST)—originally introduced by Mary Csuka and Daniel J. McCarty in 1985 (American Journal of Medicine, 78[1]:77–81) and incorporated into the landmark epidemiological battery by Jack M. Guralnik and colleagues in 1994—is a rapid, objective clinical performance outcome (PerfO) that measures functional lower-extremity muscle strength, transitional movement control, and dynamic balance. In geriatrics, neurorehabilitation, and sarcopenia clinical trials, the 5xSTS is administered either as a standalone timed test or as the third subtest of the 12-point Short Physical Performance Battery (SPPB) alongside gait speed and balance assessments such as the Timed Up and Go (TUG) test and the Berg Balance Scale.
What Is the Standardized Protocol and Geriatric Fall-Risk Cutoff (>12 to >15 Seconds) for the Five Times Sit-to-Stand Test (5xSTS / FTSST)?
To achieve reproducible test-retest reliability (ICC = 0.89–0.96) across clinical trial sites, examiners must standardize chair geometry, arm position, and stopwatch stop criteria:
- Equipment Setup: Use a sturdy, standard-height armless straight-backed chair with a seat height of 43 to 45 cm (17 to 18 inches) placed firmly against a wall so it cannot slide backward.
- Starting Posture: The participant sits in the middle of the chair with their back off the backrest, feet flat on the floor hip-width apart (heels positioned slightly behind the knees), and arms folded tightly across the chest with hands resting on opposite shoulders.
- Single Pre-Test Demonstration Stand: The examiner first asks the participant to stand up once without using their arms. If the participant cannot rise once without pushing off their thighs or the chair seat, the 5xSTS is terminated and scored as unable (0 points on the SPPB).
- Timing the 5 Repetitions: On the command “Go”, the stopwatch starts and the participant stands up fully (complete hip and knee extension) and sits back down (buttocks making firm contact with the seat) 5 times as quickly as possible. In the Guralnik SPPB protocol, timing stops when the participant achieves full upright standing position on the 5th repetition; in the Csuka/Bohannon rehabilitation protocol, timing stops when the participant’s buttocks touch the chair seat after the 5th repetition (protocols must pre-specify which stop rule is used in the trial manual of operations).
Age-Stratified Norms and Clinical Cutoffs for 5xSTS
In Richard W. Bohannon’s (2006) descriptive meta-analysis of community-dwelling older adults, worse-than-average performance is defined as exceeding the following age-specific thresholds:
- Ages 60–69 years:
>11.4 seconds - Ages 70–79 years:
>12.6 seconds - Ages 80–89 years:
>14.8 seconds
Across diagnostic and risk-stratification cohorts, peer-reviewed cutoffs include:
- Vestibular & Early Fall Screening Cutoff (
>12.0 seconds): Tiedemann et al. (2008) identified≥12.0 secondsas the threshold separating older adults with increased fall risk in community screening. - Recurrent Geriatric Fall-Risk Cutoff (
>15.0 seconds): Buatois et al. (2008, Journal of the American Geriatrics Society) demonstrated in a prospective cohort of 2,735 older adults that a 5xSTS time of>15.0 secondsindependently predicts recurrent falls (adjusted relative risk1.74). - EWGSOP2 Probable Sarcopenia Cutoff (
>15.0 seconds): The revised European Working Group on Sarcopenia in Older People (EWGSOP2, Cruz-Jentoft et al., 2019, Age and Ageing) designates5xSTS > 15.0 seconds(for 5 rises) as the primary lower-limb clinical threshold for low muscle strength (probable sarcopenia) when handgrip dynamometry is unavailable. - Parkinson’s Disease Fall Cutoff (
>16.0 seconds): Duncan et al. (2011) validated>16.0 secondsfor discriminating fallers from non-fallers in idiopathic Parkinson’s disease. - Minimal Clinically Important Difference (MCID):
1.7 secondsin COPD pulmonary rehabilitation (Jones et al., 2013) and2.3 secondsin vestibular rehabilitation (Meretta et al., 2006).
How Does the 5xSTS Integrate into the 12-Point Guralnik Short Physical Performance Battery (SPPB: Balance + 4m Gait Speed + 5xSTS)?
Developed by Jack M. Guralnik and colleagues at the National Institute on Aging (Journal of Gerontology, 1994), the Short Physical Performance Battery (SPPB) is the FDA- and EMA-recognized functional primary endpoint for physical frailty, mobility disability, and sarcopenia clinical trials (often paired with the Clinical Frailty Scale and 6-Minute Walk Test). The SPPB sums three 0–4 point subtests into a composite score from 0 to 12:
| Subtest Score | 1. Hierarchical Standing Balance (10 s each) | 2. 4-Meter Usual Gait Speed | 3. Repeated Chair Stands (5xSTS Time) |
|---|---|---|---|
| 0 points | Side-by-side stand held <10.0 s or unable |
Unable to complete 4-meter walk | Unable to complete 5 stands without arms or takes >60.0 s |
| 1 point | Side-by-side 10.0 s; semi-tandem <10.0 s |
Time >8.70 s (<0.46 m/s) |
Time ≥16.70 seconds (up to 60.0 s) |
| 2 points | Semi-tandem 10.0 s; full tandem held 0.0–2.99 s |
Time 6.21–8.70 s (0.46–0.64 m/s) |
Time 13.70–16.69 seconds |
| 3 points | Semi-tandem 10.0 s; full tandem held 3.00–9.99 s |
Time 4.82–6.20 s (0.65–0.82 m/s) |
Time 11.20–13.69 seconds |
| 4 points | Full tandem stand held for full 10.0 seconds |
Time <4.82 s (≥0.83 m/s) |
Time ≤11.19 seconds |
On the total SPPB (0–12), scores of ≤8 define severe physical performance limitation (and severe sarcopenia under EWGSOP2 when combined with low muscle mass and low strength), scores of 7–9 indicate moderate mobility limitation/pre-frailty, and scores of 10–12 indicate preserved lower-extremity function. The validated SPPB Minimal Clinically Important Difference (MCID) is 0.5 points for small meaningful change and 1.0 point for substantial meaningful change (Perera et al., 2006).
How Does the CDC STEADI 30-Second Chair Stand Test (30CST) Compare with 5xSTS for Telehealth and Sarcopenia Trials?
A known psychometric limitation of the 5xSTS in frail geriatric cohorts is its floor effect: approximately 15%–25% of hospitalized or frail community-dwelling older adults cannot complete all 5 repetitions without arm assistance, collapsing their continuous time score into a censored “unable” value. To eliminate this floor effect, C. Jessie Jones, Roberta E. Rikli, and William C. Beam (1999) developed the 30-Second Chair Stand Test (30CST), which was adopted by the CDC STEADI (Stopping Elderly Accidents, Deaths, & Injuries) fall-prevention initiative and the Osteoarthritis Research Society International (OARSI) core outcome set for knee and hip osteoarthritis:
- Count-Based Scoring (Range 0 to 25+ stands): Instead of timing 5 repetitions, the 30CST counts the total number of complete stands (arms crossed over the chest, from a 17-inch / 43 cm chair) performed in 30 seconds. A patient who can only complete 1, 2, 3, or 4 stands receives a continuous integer score (
1,2,3, or4) rather than failing the test. - CDC STEADI Age and Sex Fall-Risk Cutoffs (Below Average = High Fall Risk):
- Ages 60–64:
<14 stands(Men) /<12 stands(Women) - Ages 65–69:
<12 stands(Men) /<11 stands(Women) - Ages 70–74:
<12 stands(Men) /<10 stands(Women) - Ages 75–79:
<11 stands(Men) /<10 stands(Women) - Ages 80–84:
<10 stands(Men) /<9 stands(Women) - Ages 85–89:
<8 stands(Men) /<8 stands(Women)
- Ages 60–64:
- Advantage in Synchronous Telerehabilitation: In video-based telerehabilitation and decentralized clinical trials, network latency (
100–300 msvideo jitter) can introduce stopwatch error on a short 9-second 5xSTS trial, whereas counting integer stands over a fixed 30-second window on the 30CST achieves near-perfect inter-rater agreement between remote video and in-person raters.
Frequently Asked Questions
What is the standardized protocol and geriatric fall-risk cutoff (>12 to >15 seconds) for the Five Times Sit-to-Stand Test (5xSTS / FTSST)?
Using a standard 43–45 cm (17-inch) armless chair with the participant’s arms folded across their chest, the examiner times how fast the participant completes 5 full stands. Times exceeding 12.0 seconds indicate general mobility impairment and early fall risk, while times exceeding 15.0 seconds predict recurrent geriatric falls (Buatois et al., 2008) and define probable lower-limb sarcopenia under EWGSOP2 criteria.
How does the 5xSTS integrate into the 12-point Guralnik Short Physical Performance Battery (SPPB: balance + 4m gait speed + 5xSTS)?
In the 12-point Guralnik SPPB, the 5xSTS contributes 0–4 points alongside standing balance (0–4 points) and 4-meter gait speed (0–4 points): ≤11.19 s scores 4 points, 11.20–13.69 s scores 3 points, 13.70–16.69 s scores 2 points, ≥16.70 s scores 1 point, and inability to complete 5 stands without arms (or taking >60 s) scores 0 points.
How does the CDC STEADI 30-Second Chair Stand Test (30CST) compare with 5xSTS for telehealth and sarcopenia (EWGSOP2) trials?
Whereas the 5xSTS measures the time required to complete 5 stands (creating a floor effect if a frail patient can only stand 1–4 times), the CDC STEADI 30-Second Chair Stand Test counts the total number of full stands completed in 30 seconds, eliminating floor effects in frail cohorts and reducing network-latency timing error during remote video telerehabilitation assessments.







